News Hub | News Direct

Education

Higher Education Preschool Primary/Secondary
Article thumbnail News Release

San Diego Foundation Launches National Rainbow College Fund in California

National Rainbow College Fund

Today, San Diego Foundation (SDF) launched the National Rainbow College Fund (NRCF) in California, the first scholarship designed to exclusively support LGBTQ+ students pursuing their ambitions for higher education regardless of the public nature of their sexual and gender identity. The National Rainbow College Fund is powered by San Diego Foundation, one of the largest community foundations in the U.S. and the largest provider of scholarships of any community foundation in California. The mission of the National Rainbow College Fund is to lessen the financial burden for young people who identify as LGBTQ+ or who are grappling with the secrecy of remaining in the closet. The groundbreaking fund addresses the unique challenges LGBTQ+ students face such as social acceptance, mental health issues and family rejection that can hinder their ability to afford college that in turn impacts long-term economic earning power. “Speaking from personal experience, I know that many young people struggle with the fear of being outed or coming out. It can be overwhelming. Like many young people, I did everything possible to hide who I was because I feared being kicked out of my home and my family, as well as being cut off financially and emotionally,” said Mark Stuart, President and CEO of San Diego Foundation. “Every LGBTQ+ person should have the means to realize their educational dreams, regardless of the public nature of their sexual and gender identity.” The $2,500 award per selected student may be used for tuition, books, fees, room and board and other educational expenses. It does not need to be repaid. The application period is from January 15, 2025 – March 5, 2025. San Diego Foundation will make students’ privacy the highest priority during the application process. All information submitted to the application portal will be confidential. Setting the precedent in California, San Diego Foundation’s vision is for the fund to grow to be a national source of financial aid for LGBTQ+ students to attend the technical school, college or university of their choosing. To apply, a student who identifies as LGBTQ+ whether publicly or privately must be a high school senior; an incoming or current college or university student; or an adult re-entry student. Applicants need to have lived in California for at least one year and must demonstrate financial need by completing the Free Application for Federal Student Aid (FAFSA), the California DREAM Act Application or the Federal Student Aid Estimator Tool. Students must plan to enroll in at least 6 units in an accredited public or nonprofit community college; four-year university or trade/vocational school anywhere within the United States. For more details about eligibility and selection criteria, please visit rainbowcollegefund.org/scholarship-program/. The need for this scholarship is well-documented. According to a survey conducted by Student Loan Hero, LGBTQ+ students face significant barriers in paying for their education. Families may not financially support their children, leading LGBTQ+ students to turn to loans to finance their schooling. LGBTQ+ borrowers had a higher debt burden on average, with $16,000 more than their cisgender/heterosexual peers: 60% of LGBTQ+ student loan borrowers regret taking out student loans; 28% feel that they can’t manage their student loan payments and more than 53% reported earning less than $50,000 per year. For every $1,000 scholarship a student receives, they are 5% more likely to complete their education. Privacy remains a major concern. A 2022 study from the Williams Institute found that LGBTQ+ students are four times more likely than non-LGBTQ+ students to choose college in a state with a more welcoming climate and to live away from family; 60% of white LGBTQ+ students are not out to staff/faculty and less than 40% of LGBTQ+ students of color are out to staff/faculty. Community colleges have even higher rates of keeping sexual identity private: more than 70% white LGBTQ+ students and 65% LGBTQ+ students of color are not out. LGBTQ+ rights have been under increased attack in general, but also transgender and gender diverse communities in particular. This political landscape is the backdrop by which teenagers are navigating their identities while emerging into adulthood. The Centers for Disease Control and Prevention published a study documenting that approximately 3.3% of high school students identify as transgender and another 2.2% are questioning their gender identity. Transgender and gender-questioning teenagers reported alarmingly higher rates of bullying at school, persistent sadness and suicidal thoughts and behavior. About one in four transgender students said they had attempted suicide in the past year, compared with 11% of cisgender girls and 5% of cisgender boys. * * * About National Rainbow College Fund National Rainbow College Fund (NRCF) is the first scholarship designed to exclusively support LGBTQ+ students pursuing their ambitions for higher education regardless of the public nature of the student’s sexual and gender identity. The groundbreaking fund addresses the unique challenges LGBTQ+ students face such as social acceptance, mental health issues and family rejection that can hinder their ability to afford college that in turn impacts long-term economic earning power. Setting the precedent in California, San Diego Foundation’s vision is for the fund to grow to be a national source of financial aid for LGBTQ+ students to attend the technical school, college or university of their choosing. Learn more at RainbowCollegeFund.org. Follow NRCF on social media: Instagram: @RainbowCollegeFund, Facebook: Rainbow College Fund, X (formerly Twitter): @RainbowColFund, LinkedIn: Rainbow-College-Fund About San Diego Foundation For nearly 50 years, San Diego Foundation has been inspiring enduring philanthropy and enabling community solutions to improve the quality of life in our region. Our strategic priorities include advancing racial and social justice, fostering equity of opportunity, building resilient communities, and delivering world-class philanthropy to realize our vision of just, equitable and resilient communities. Since our founding in 1975, SDF and our donors have granted $2 billion to support nonprofit organizations strengthening our community. Join us in commemorating 50 years of impact – and looking toward the next 50. Learn more at SDFoundation.org. Contact Details Landis Communications Inc. Cheryl Reiss +1 415-640-5431 NRCF@landispr.com Company Website https://rainbowcollegefund.org/

October 31, 2024 09:00 AM Pacific Daylight Time

Image
Article thumbnail News Release

Greg Olsen's Youth Inc. Expands with New Podcast Season and Upcoming Commerce Platform

Youth Inc.

Youth Inc., the first digital media network dedicated exclusively to youth sports content and commerce, today announced that Season Two of its popular Youth Inc. Podcast will launch on Wednesday, Oct. 30. Following the company’s 2024 $4.5 million seed funding round, led by Will Ventures, Youth Inc. is developing a new centralized hub blending news, original content, and retail for the youth sports market. Launched in 2022, Season One of the Youth Inc. Podcast featured conversations with iconic athletes like Jerry Rice, Russell Wilson, Jennie Finch, and Dale Earnhardt Jr. After a breakout debut season with more than 400,000 downloads, millions of impressions, and a nearly perfect viewership rating, Youth Inc. Is expanding its vision as it prepares to launch Season Two. Co-founded by Emmy Award-winning NFL analyst and Pro Bowl tight end Greg Olsen, former Fanatics executive Ryan Baise and Audacy, Inc.’s Tim Murphy, the podcast will feature acclaimed sports psychologist Dr. Michael Gervais as co-host, offering crucial insights for navigating today’s complex youth sports landscape. “While there are more than 30 million young athletes in our country today, there has never been a platform designed to speak directly to families, coaches, and players about the challenges of today’s current state of play,” said Olsen. “Season one taught us invaluable lessons, and we're excited to bring even more insights and depth in Season Two. Partnering with Dr. Gervais, we’ll provide our audience with the tools and knowledge to succeed, all while making the journey engaging and enjoyable." Season Two of the podcast will address the critical challenges young athletes face today including fostering resilience, managing the pressures of competition, and leveraging mindset training for long-term success. The six-episode season is presented by two Founding Partners: Players Health, a sports technology company offering digital risk management services and insurance products to ensure a secure environment for athletes, and MaxU, a cutting-edge platform providing personalized, 24/7 support to help young athletes build skills that enhance their mental performance and overall development. As Youth Inc. enhances its content offerings, it is also set to launch a robust commerce platform in early 2025, designed to further support young athletes and their families. Led by former Fanatics head of new ventures, Ryan Baise, the platform will offer a range of products and services tailored specifically for youth sports families and coaches. "The youth sports landscape is ripe for transformation, and we believe our platform will revolutionize how families access vital information and resources," said Baise. "Our aim is to create a comprehensive marketplace where parents, athletes, and coaches can discover rigorously vetted content and products that reflect the investment they make in their young athletes' futures." To listen to Season One of the Youth Inc. podcast (available on major podcast platforms, YouTube, and social media in both video and audio formats), watch the Season Two trailer or for more information, please visit Youth Inc. Youth Inc. is the first digital media network dedicated exclusively to youth sports content and commerce. Co-founded by NFL alum and Fox Sports broadcaster Greg Olsen, former Fanatics executive, Ryan Baise, and former Audacy and New York Times Co. executive, Tim Murphy, Youth Inc. provides parents, coaches, and athletes with expert-driven guidance and resources to navigate the evolving youth sports landscape. For more information, visit www.youth.inc or follow along on YouTube, Instagram, X, and TikTok. Contact Details Youth Inc. Jackson Gaskins jgaskins@hotpaperlantern.com

October 28, 2024 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Players Health Becomes Founding Partner of Greg Olsen’s Youth Inc. to Champion Safety in Youth Sports

Players Health

Players Health, the leading provider of athlete safety and insurance solutions, today announced its partnership as a founding partner with Youth Inc., a content and commerce platform co-founded by NFL alum and Fox Sports broadcaster Greg Olsen. This collaboration marks a significant step toward enhancing safety standards in youth sports through engaging and informative content. It will offer valuable education for athletes, parents, and coaches, while promoting a culture of safety, risk management, and athlete well-being across all levels of play. As digital advertising evolves, and the youth sports industry continues to soar, the growing importance of community-driven strategies and content creation is fueling shifts in the way youth sports organizations engage with their audiences. Through this partnership, Players Health and Youth Inc. will collaboratively generate and distribute content that helps those entrusted with leading youth sports organizations create a safer and more informed environment for young athletes, parents, and coaches. “In today’s rapidly changing youth sports landscape, health and safety must remain at the forefront. Our partnership with Youth Inc. provides a unique opportunity to speak directly to changemakers in our industry and around the country, equipping them with the tools and insights needed to proactively address the challenges facing youth athletes today,” said Tyrre Burks, founder and CEO of Players Health. “Together, we’re not just providing solutions — we’re leading a movement to transform how health and safety is prioritized in youth sports." Youth Inc. provides content across all media platforms, including full-length video/audio podcasts available on YouTube, Spotify, and Apple Podcasts. The network also shares clips on Instagram, Facebook, TikTok, LinkedIn and X. Featuring interviews with some of the biggest stars and thought leaders in the sports world, Youth Inc. serves as a vital resource for navigating the complexities of youth sports today. "Youth sports should be a place where kids can grow, learn, and have fun, and that starts with creating a safe environment. Through our partnership with Players Health, we’re able to provide families and organizations with expert-driven content and resources to help navigate the challenges of today’s youth sports landscape,” said Olsen. “Our shared vision is to equip everyone involved with the knowledge and support they need to foster a safer, more positive experience for young athletes." Season two of Youth Inc. launches on Wednesday, October 30th with six new episodes. Fans, coaches, parents and young athletes can look forward to deeper conversations with top athletes, coaches, and experts in youth sports, as well as valuable advice on safety, well-being, and athletic development. This season promises to bring more exclusive content, further solidifying Players Health and Youth Inc.'s roles as a leading voice in youth sports education. The trailer for Youth Inc.’s upcoming season, featuring Players Health, Greg Olsen, and renowned sports psychologist Dr. Michael Gervais, offers a glimpse into the impactful conversations and expert commentary that will shape the future of youth sports safety and development. To learn more, visit: https://www.playershealth.com/ About Players Health Players Health is a sports technology company providing digital risk management services, reporting tools and insurance products to sports organizations to empower them to stay ahead of their ever-changing safety and compliance responsibilities. Working towards establishing the safest environment for athletes, Players Health views the health and safety of athletes as a priority in today's sports landscape. About Youth Inc. Youth Inc. is the first digital media network dedicated exclusively to youth sports content and commerce. Co-founded by NFL alum and Fox Sports broadcaster Greg Olsen, Youth Inc. provides parents, coaches, and athletes with expert-driven guidance and resources to navigate the evolving youth sports landscape. For more information, visit www.youth.inc or follow along on YouTube, X, and TikTok. Contact Details Players Health Jackson Gaskins playershealth@hotpaperlantern.com Company Website https://www.playershealth.com

October 21, 2024 09:00 AM Eastern Daylight Time

Article thumbnail News Release

Silexion Therapeutics to Present at 2024 Maxim Healthcare Virtual Summit

Silexion Therapeutics Corp

Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotech developing RNA interference (RNAi) therapies for KRAS-driven cancers, today announced its participation in the 2024 Maxim Healthcare Virtual Summit, scheduled to take place from October 15 to 17, 2024. Ilan Hadar, Chief Executive Officer and Dr. Mitchell Shirvan, Chief Scientific and Development Officer will join a fireside chat hosted by Jason McCarthy, Senior Managing Director and Head of Biotechnology Research at Maxim Group, on Thursday, October 17, 2024, at 9:30am ET. The event will be streamed live on M-Vest and accessible to members by clicking here or via following link: https://m-vest.com/events/healthcare-10152024. The Company’s management team will be available for one-on-one meetings throughout the summit. Interested investors are encouraged to contact their Maxim representative to schedule a meeting. About Silexion Therapeutics: Silexion Therapeutics (NASDAQ: SLXN) is a pioneering clinical-stage, oncology-focused biotechnology company developing innovative RNA interference (RNAi) therapies to treat solid tumors driven by KRAS mutations, the most common oncogenic driver in human cancers. The company's first-generation product, LODER™, has shown promising results in a Phase 2 trial for non-resectable pancreatic cancer. Silexion is also advancing its next-generation siRNA candidate, SIL-204, designed to target a broader range of KRAS mutations and showing significant potential in preclinical studies. The company remains committed to pushing the boundaries of therapeutic innovation in oncology, with a focus on improving outcomes for patients with difficult-to-treat cancers. For more information please visit: https://silexion.com Contact Details Silexion Therapeutics Corp Ms. Mirit Horenshtein Hadar, CFO mirit@silexion.com ARX | Capital Markets Advisors North American Equities Desk silexion@arxadvisory.com

October 09, 2024 04:30 PM Eastern Daylight Time

Article thumbnail News Release

Amesite Reports Its NurseMagic App Is Ramping Up Users As Social Media Attention Goes Viral, Company Inks More Health Professional Business Deals

Benzinga

By Meg Flippin, Benzinga Many nurses and caregivers are stressed out and overworked, leading to high turnover and big shortages. This is of particular concern in the home healthcare arena, where more than 1 in 4 nurses plan to leave the profession by 2027. The ones who stay need more support, and thousands are finding it with Amesite’s (NASDAQ: AMST) NurseMagic™, a proprietary AI app designed for nurses. The app is capable of quickly creating nursing notes, a requirement for professionals ranging from CNAs and LPNs to APRN-CNPs and NPs and a daily shift task which Amesite says takes up 40% of nurses' time. Caregivers can also use the app to explain medical procedures in easy-to-understand language, create work emails, give guidance on patient and family communication, provide coaching on taking wellness breaks during the day, provide key information about medications and more. Fast Growing Usership And Five-Star Reviews NurseMagic | AI Tools for Nurses leverages Amesite’s cloud infrastructure and expertise in AI integrations and AI-powered features. Amesite entered the market with its Amesite Engage platform and reports that it has accelerated customer acquisition after streamlining its infrastructure to deliver systems at very low incremental cost. Now Amesite reports that it is signing with community colleges across the country that are tapping Amesite to train the workers of tomorrow. The company reports being encouraged by its no-setup-fee model, which was followed by the signing seven new community college deals across the U.S. With that experience, it was only natural that Amesite would pivot into healthcare. After all, there are more than five million nurses and an additional 3.9 million home health workers in the country, and surveys support the strong need for more support among nurses and healthcare professionals. Within eight weeks of its beta stage debut, NurseMagic witnessed triple-digit monthly growth driven in part by its presence on social media. Amesite has engaged with prominent influencers including Paige Slayton, Nurse Cynesse, Nurse Tara and Nurse Hailey. Combined, that gives Amesite access to over three million followers. The engagement with Nurse Hailey alone was responsible for a 27% increase in users. From June to July the app has seen 830% growth in registered users. NurseMagic also recently debuted in the Apple App Store, charting at #33 in the medical category after only four weeks in the store and garnering five-star reviews. The app is now being used by nurses and healthcare professionals in all 50 states and six countries. “The 27% increase in users following the most recent social post demonstrates both the incredible impact of influencers voicing the capabilities of NurseMagic and the power of the app itself,” said Madison Bush, Corporate Operations and Marketing Manager at Amesite. “Charting for the first time after only a few weeks in the App Store is incredibly exciting and validates the utility of NurseMagic as a mobile tool for a wide variety of healthcare professionals.” Amesite says a big driver of user engagement is the accuracy and speed of the app. The company reports that it relies on qualified data sources that have proven to be accurate and reliable. It uses this data to train its more than 20 proprietary AI models to ensure performance – and adds an average of five new features per week. At last check, Amesite indicated it has integrated more than 100 APIs into its company tech stack, including connections to government databases, authentication services, payment gateways and AI-powered tools. The app’s models have also demonstrated 93% accuracy when tested against NCLEX test questions. The NCLEX exam is a standardized exam developed by the National Council of State Boards of Nursing (NCSBN) that nursing graduates must pass to obtain their nursing licenses in the United States and Canada. Amesite reports feedback from customers has “been extremely positive.” 15X ROI For Enterprise NurseMagic Customers It’s not just individual nurses that are interested in NurseMagic. A variety of healthcare professionals are using NurseMagic, with Amesite recently announcing the launch of pilot programs in five home health agencies and skilled nursing facilities across the United States. Amesite said that collectively, these companies and their franchisees have over 30,000 employees providing skilled nursing, hospice care and home healthcare. The latter is a large and growing sector in need of support. Home healthcare is valued at $100 billion today and is projected to grow to $176 billion by 2032. It's also an area that is seeing job growth of about 21% per year through 2032, presenting a lucrative opportunity for Amesite. The company estimates that its customers will achieve a whopping 15X ROI with its product, based on the expected increase in efficiency of workers using the app and expected pricing. “We anticipate very significant quarter-to-quarter revenue increases with NurseMagic,” said Amesite founder and CEO Dr. Ann Marie Sastry. “For less than 2% of the cost of wages, our technology can make this entire workforce at least 30% more productive, while simultaneously improving the quality of patient care. Because of the efficiency of our systems, we believe that we can do so at highly attractive margins that enable sustained growth.“ As of May 10, 2024, the company reported it had $3 million of cash in hand and 10 months of burn on hand, even assuming no new revenue, reflecting its liquidity position. The company is bullish on building revenue through its B2B and B2C NurseMagic products, while simultaneously continuing to offer its higher education platform at low incremental cost. The company reported a reduction in SG&A of nearly 50% YOY from FY22 to FY24 and expects to continue finding efficiencies. Nurses are in demand as acute turnover continues to concern the industry, and many of them are in need of some support – and NurseMagic offers that support. It seeks to tap an unmet need and help meet it with an assist from AI. To learn more about the app and Amesite, click here. Featured photo by PeopleImages.com - Yuri A on Shutterstock. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 26, 2024 08:45 AM Eastern Daylight Time

Image
Article thumbnail News Release

How NurseMagic Helps Patients Recieve The Care They Deserve

Benzinga

By Johnny Rice, Benzinga Dr. Ann Marie Sastry, CEO & Founder of Amesite Inc. (NASDAQ: AMST), was recently interviewed by Benzinga. Amesite specializes in the development and marketing of B2C and B2B AI-driven solutions. Harnessing the power of AI to build better educational platforms, Amesite empowers clients in higher education, businesses, medicine and government. The company creates custom solutions tailored to the specific needs of its clients. Dr. Sastry spoke about the incredible new app the company recently rolled out called NurseMagic which will help medical providers across the industry. Watch the full interview here: Featured photo by Piron Guillaume on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

September 20, 2024 09:15 AM Eastern Daylight Time

Video Image
Article thumbnail News Release

Join Travis Kelce for the Second Annual "Kelce Car Jam" - A Celebration of Cars, Community, and Youth Empowerment.

Full Scope PR

Gear up for an exhilarating evening filled with cars, community, and camaraderie at the 2nd Annual Kelce Car Jam taking place on Saturday, October 5, 2024, from 5-8pm CT. This year’s event, held on Walnut Street in downtown Kansas City, promises to be a thrilling block party that perfectly sets the stage for the Chiefs' Monday Night Football game. Join three-time Super Bowl champion Travis Kelce and his Kansas City Chief teammates as they showcase some of the city’s coolest vintage and luxury cars, including select vehicles from their personal collections. This vibrant event is not just a car show; it's a celebration of community spirit, designed to bring together fans from all walks of life. Adding to the excitement, the talented kids from Operation Breakthrough Ignition Lab will be joining us to show off some of their automotive work. Operation Breakthrough's Ignition Lab is a state-of-the-art STEM workspace that Travis Kelce helped open and has significantly supported. This lab is designed to provide real-world learning opportunities in STEM for high school students, preparing them for future careers and life. They'll present their impressive automotive projects and offer a taste of culinary delight from their newly refurbished food truck. This initiative, supported by the Eighty-Seven & Running Foundation, underscores Travis Kelce’s commitment to empowering youth through education and opportunity. The Kelce Car Jam offers fun for all ages with a variety of food, drinks, and activities from our partners: Raising Cane’s Chicken Fingers, Travis Kelce’s Kitchen BBQ and Andy’s Frozen Custard. Attendees can choose between two ticket levels: General Admission or VIP. The VIP experience includes intimate access to an exclusive indoor space, complete with food and drinks. Tickets will go on sale starting Wednesday, September 4th and can be purchased at 87running.org. Don’t miss out on this unique opportunity to experience the magic of Kelce Car Jam, where the love for cars meets the heart of the community. Secure your tickets now and be part of a night to remember! About Eighty-Seven & Running The Eighty-Seven & Running Foundation is dedicated to empowering Kansas City's youth by providing vital resources and support to those who are undeserved and vulnerable. The foundation is committed to fostering community, encouraging personal growth, and paving a path to success for these young individuals. Contact Details Full Scope PR Team Travis Kelce tk@fullscopepr.com Eighty-Seven & Running Foundation Info info@87running.org Company Website https://87running.org/

September 04, 2024 07:00 AM Central Daylight Time

Article thumbnail News Release

Nuvectis Pharma Rises in Pre-Market Following FDA Orphan Drug Designation for NXP800, Fueling Optimism Ahead of Key Clinical Data

Global Markets News

Nuvectis Pharma (NASDAQ: NVCT) has achieved a significant milestone with the U.S. Food and Drug Administration (FDA) granting Orphan Drug Designation for its lead candidate, NXP800. This designation, specifically for the treatment of ARID1a-deficient ovarian, fallopian tube, and primary peritoneal cancers, marks a critical step forward in Nuvectis’s mission to address unmet needs in oncology. Orphan Drug Designation: A Strategic Advantage The FDA’s Orphan Drug Designation is awarded to drugs that show promise in treating rare diseases affecting fewer than 200,000 people in the U.S. For Nuvectis, this designation not only validates the potential of NXP800 but also provides several strategic benefits. These include tax credits for clinical trial costs, exemption from certain FDA fees, and potentially seven years of market exclusivity upon approval. NXP800 targets ARID1a-deficient cancers, a subset of ovarian cancers that present significant treatment challenges. The Orphan Drug Designation underscores the importance of this candidate in potentially offering a new, more effective treatment option for patients with this specific genetic mutation. Background and Market Impact This latest achievement builds on Nuvectis Pharma’s earlier successes. Earlier this year, the FDA granted Fast Track Designation to NXP800 for its development in platinum-resistant, ARID1a-mutated ovarian cancer. The Fast Track status, combined with the Orphan Drug Designation, highlights the urgent need for innovative treatments in this space and positions NXP800 as a potential game-changer in oncology. Financial analysts have taken note of Nuvectis’s progress. H.C. Wainwright recently reiterated its buy rating for Nuvectis, setting a price target of $21. This optimistic outlook reflects the market’s confidence in the company’s strategic direction, particularly as it prepares to release key clinical data later this year. Anticipation for Upcoming Results The next few months are expected to be pivotal for Nuvectis Pharma. The company is poised to share updates from its ongoing Phase 1b clinical trial of NXP800, which targets patients with platinum-resistant, ARID1a-mutated ovarian cancer. This trial is being closely watched, as positive results could significantly advance the development of NXP800, bringing it closer to pivotal trials and eventual regulatory approval. Additionally, Nuvectis is also conducting a Phase 1a dose escalation study for NXP900, its second key candidate, which targets YES1/SRC-driven tumors. Updates from this study are expected to provide further insights into the safety and potential efficacy of NXP900. ### Nuvvectis' Full announcment, titled " Nuvectis Pharma Announces Orphan Drug Designation Granted by the FDA for NXP800 for the Treatment of ARID1a-deficient Ovarian, Fallopian Tube, and Primary Peritoneal Cancers" was published on August 29th, 2024. ### This article is for informational purposes only and is not intended to serve as financial, investment or any form of professional advice, recommendation or endorsement. Please review the full documentation detailing financial compensation disclosures and disclaimers the article is subject to. https://justpaste.it/fcm9n/pdf. Global Markets News Network is a commercial digital brand compensated to provide coverage of innovative companies and industries and it is thus subject to conflicts of interest. Contact Details Global Markets News News Coverage ronald@futuremarketsresearch.com

August 29, 2024 08:20 AM Eastern Daylight Time

Article thumbnail News Release

Navigate your Investment Roadmap with Select Sector SPDR ETFs

Select Sector SPDR

In an era where market dynamics shift as swiftly as the winds, Select Sector SPDR ETFs remain a beacon for investors aiming to harness the potential of sector-specific investments. Tailored to meet the diverse needs of both individual and institutional investors, these ETFs chart a course for strategic portfolio management by distilling the vast S&P 500 into accessible segments. Focused Investment Across Diverse Sectors Select Sector SPDR ETFs stand out by offering a focused approach to investing, breaking down the broad landscape of the S&P 500 into key sectors. This segmentation allows investors to pinpoint their investments according to specific economic areas, aligning their portfolios with their investment goals, risk assessments, and market perspectives. Below is a glimpse into the diverse holdings that form the core of the Select Sector SPDR ETFs: Communication Services Select Sector SPDR Fund (XLC): Zooms in on the telecommunications and media sectors, capturing the pulse of digital communication. Consumer Discretionary Select Sector SPDR Fund (XLY): Targets the vibrant consumer goods and services sector, from retail giants to entertainment behemoths. Consumer Staples Select Sector SPDR Fund (XLP): Focuses on essential consumer goods and services, providing stability in fluctuating markets. Energy Select Sector SPDR Fund (XLE): Powers through with a dedicated look at the energy sector, from fossil fuels to renewable resources. Financials Select Sector SPDR Fund (XLF): Encompasses the robust banking, investment, and insurance industries, the backbone of economic infrastructure. Health Care Select Sector SPDR Fund (XLV): Centers on the pharmaceuticals, healthcare equipment, and services sectors, addressing global health needs. Industrials Select Sector SPDR Fund (XLI): Broadens the horizon with manufacturing, construction, and logistics firms. Materials Select Sector SPDR Fund (XLB): Covers the foundational chemicals, construction materials, and packaging industries. Real Estate Select Sector SPDR Fund (XLRE): Opens doors to commercial real estate services and REITs. Technology Select Sector SPDR Fund (XLK): Accelerates into the information technology and electronics sectors, powering innovation and connectivity. Utilities Select Sector SPDR Fund (XLU): Illuminates the path with utility companies, ensuring the flow of essential services. A Path for Strategic Investment By offering a lens through which to invest in specific sectors, Select Sector SPDR ETFs enable investors to steer their portfolios with confidence and clarity. The ETFs’ commitment to transparency and strategic focus empowers investors to adapt and thrive amidst the ebb and flow of market conditions. In the evolving landscape of the financial markets, Select Sector SPDR ETFs stand as a testament to the power of targeted investment. Through detailed sector analysis and dedicated portfolio exposure, these ETFs offer a distinguished pathway for those seeking to refine their investment strategies with sector-specific allocations. About Select Sector SPDR ETFs Select Sector SPDR ETFs are a series of exchange-traded funds designed to provide investors with an effective way to engage in sector-specific investment strategies. By segmenting the S&P 500 into distinct sectors, Select Sector SPDR ETFs furnish investors with the tools necessary for targeted and strategic investment decisions. DISCLAIMER: This is a work of research and should not be taken as investment or financial advice. Therefore, Select Sector SPDRs or the publisher is not liable for any decision made based on the publication. About the Company: Select Sector SPDR ETFs offer flexibility and customization opportunities. Many investors have similar outlooks, but no two are exactly alike. Select Sector SPDR ETFs let investors select the sectors that best meet their investment goals. DISCLOSURES The S&P 500 Index is an unmanaged index of 500 common stocks that is generally considered representative of the U.S. stock market. The index is heavily weighted toward stocks with large market capitalizations and represents approximately two-thirds of the total market value of all domestic common stocks. The S&P 500 Index figures do not reflect any fees, expenses or taxes. An investor should consider investment objectives, risks, fees and expenses before investing. One may not invest directly in an index. Transparent ETFs provide daily disclosure of portfolio holdings and weightings All ETFs are subject to risk, including loss of principal. Sector ETF products are also subject to sector risk and nondiversification risk, which generally will result in greater price fluctuations than the overall market. Diversification does not eliminate risk. An investor should consider investment objectives, risks, charges and expenses carefully before investing. To obtain a prospectus, which contains this and other information, call 1-866-SECTOR-ETF (732-8673) or visit www.sectorspdrs.com. Read the prospectus carefully before investing. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is distributor for the Select Sector SPDR Trust. Media Contact: Company: Select Sector SPDRs Contact: Dan Dolan* Address: 1290 Broadway, Suite 1000, Denver, CO 80203 Country: United States Email: dan.dolan@sectorspdrs.com Website: https://www.sectorspdrs.com/ *Dan Dolan is a Registered Representative of ALPS Portfolio Solutions Distributor, Inc. ALPS Portfolio Solutions Distributor, Inc., a registered broker-dealer, is the distributor for the Select Sector SPDR Trust. SEL007734 EXP 10/31/24 Contact Details Dan Dolan +1 203-935-8103 dan.dolan@sectorspdrs.com Company Website https://www.sectorspdrs.com/

August 22, 2024 05:00 AM Eastern Daylight Time

12345 ... 43